PMC 2734380
Recalls & Warnings May 01, 2024 FDA Warns Consumers Not to Use Ossos-Sans Supplement for Joints On April 17, 2024, the FDA warned consumers not to purchase or use Ossos-Sans, a supplement promoted to treat osteoarthritis, osteoporosis, and other conditions, because it contains undeclared drugs, including diclofenac and methocarbamol
Filtering out the excess niclosamide preserves the achieved amount in solution
Although the majority of deficiencies occur in developing countries such as in Africa (e.g., Cte dIvoire 14 ) and Asia (e.g., India 15 and Cambodia 13 ), also populations in developed countries can suffer from riboflavin deficiency due to inadequate intake via diet as a result of veganism 16,17 , lactose intolerance 18 , aging 19 , anorexia nervosa 20 , or alcoholism 21